224 related articles for article (PubMed ID: 19144138)
21. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.
de Rooij M; Crienen S; Witjes JA; Barentsz JO; Rovers MM; Grutters JP
Eur Urol; 2014 Sep; 66(3):430-6. PubMed ID: 24377803
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of breast cancer screening in women on dialysis.
Wong G; Howard K; Chapman JR; Craig JC
Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.
Ahern CH; Shen Y
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):718-25. PubMed ID: 19258473
[TBL] [Abstract][Full Text] [Related]
26. Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI.
Feig S
Obstet Gynecol Clin North Am; 2011 Mar; 38(1):179-96, ix. PubMed ID: 21419333
[TBL] [Abstract][Full Text] [Related]
27. The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30-49.
Norman RP; Evans DG; Easton DF; Young KC
Eur J Health Econ; 2007 Jun; 8(2):137-44. PubMed ID: 17347845
[TBL] [Abstract][Full Text] [Related]
28. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of Cost-effectiveness of screening for breast cancer with conventional mammography, digital and magnetic resonance imaging].
Peregrino AA; Vianna CM; de Almeida CE; Gonzáles GB; Machado SC; Costa e Silva FV; Rodrigues MP
Cien Saude Colet; 2012 Jan; 17(1):215-22. PubMed ID: 22218554
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.
Salzmann P; Kerlikowske K; Phillips K
Ann Intern Med; 1997 Dec; 127(11):955-65. PubMed ID: 9412300
[TBL] [Abstract][Full Text] [Related]
31. Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts.
Lee CI; Cevik M; Alagoz O; Sprague BL; Tosteson AN; Miglioretti DL; Kerlikowske K; Stout NK; Jarvik JG; Ramsey SD; Lehman CD
Radiology; 2015 Mar; 274(3):772-80. PubMed ID: 25350548
[TBL] [Abstract][Full Text] [Related]
32. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
[TBL] [Abstract][Full Text] [Related]
33. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
Arguedas MR; Chen VK; Eloubeidi MA; Fallon MB
Am J Gastroenterol; 2003 Mar; 98(3):679-90. PubMed ID: 12650806
[TBL] [Abstract][Full Text] [Related]
34. Screening for breast cancer: an update for the U.S. Preventive Services Task Force.
Nelson HD; Tyne K; Naik A; Bougatsos C; Chan BK; Humphrey L;
Ann Intern Med; 2009 Nov; 151(10):727-37, W237-42. PubMed ID: 19920273
[TBL] [Abstract][Full Text] [Related]
35. A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer.
Tumeh JW; Shenoy PJ; Moore SG; Kauh J; Flowers C
Am J Clin Oncol; 2009 Feb; 32(1):49-55. PubMed ID: 19194125
[TBL] [Abstract][Full Text] [Related]
36. Screening for proteinuria in US adults: a cost-effectiveness analysis.
Boulware LE; Jaar BG; Tarver-Carr ME; Brancati FL; Powe NR
JAMA; 2003 Dec; 290(23):3101-14. PubMed ID: 14679273
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
Feig S
Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
[TBL] [Abstract][Full Text] [Related]
39. Computer-aided detection of breast cancer: a cost-effectiveness study.
Lindfors KK; McGahan MC; Rosenquist CJ; Hurlock GS
Radiology; 2006 Jun; 239(3):710-7. PubMed ID: 16569787
[TBL] [Abstract][Full Text] [Related]
40. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
Chan CK; Gangwani RA; McGhee SM; Lian J; Wong DS
Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
